Biotech · Private company · San Antonio, TX, US
Keraceuticals, Inc.
Track this companyFree. Adds Keraceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- 1,3-Thioureas as First In Class Mitochondrial Inhibitors to Treat Oral CancerFiscal year 2024 · $399.6KNIH RePORTER 1R41DE034719-01A1 · fetched Nov 12, 2026